Dr. Reid Bowman, Co-Founder, Vice President of Research and Development, & Chief Technology Officer

Dr. Reid Bowman is a co-founder of Applied Process Technology, Inc. (Applied) as well as its Vice President of Research and Development and Chief Technology Officer. He is the "first among equals" in Applied's exemplary team of managers and scientists.

A co-inventor of Applied's cornerstone HiPOx technology, Dr. Bowman oversees Applied's new product development projects and conducts laboratory experimentation focused on improving upon HiPOx and developing other value-added water treatment technologies and solutions. Dr. Bowman conducted a successful trial of the HiPOx technology for the destruction of methyl tertiary-butyl ether (MTBE) and tertiary-butyl alcohol (TBA) validated by the U.S. Environmental Protection Agency (EPA).

A leading research scientist, featured speaker, and expert in his field, Dr. Bowman has made more than 25 presentations of the HiPOx technology at national conferences and has published numerous technical articles in well known trade journals including Water & Wastewater Products Magazine, Journal AWWA, and the US EPA’s Technology News & Trends newsletter.

Bowman brings impeccable scientific credentials to his role as Applied's CTO. During his 20-year career at Dow Chemical Corporation, Bowman developed several materials, processes and designs that produced millions of dollars of revenue in new markets and/or cost savings in old markets. He was the youngest person ever in the history of Dow Chemical to have achieved the elite rank of Associate Scientist.

Bowman's past projects include managing a $5 million polybenzozole pilot plant for the high-performance film and fiber market. He also produced next generation products for existing markets, including Broadstrike, a highly effective, low toxicity herbicide developed for corn and soybean growers, and a new polymeric absorbent that removes organic vapor from compressed air.

Bowman's designs and processes have won considerable acclaim. At Dow, his improved design for membrane skids reduced annual warranty costs by $2 million. His process design for Merrell Dow's cordiotonic enoximone was the first to overcome toxicity challenges in that chemical's manufacture, thus paving the way for commercialization. Later in his career, Bowman designed a pilot plant for biaxially oriented high-modules film for the magnetic storage and structure film market.

Dr. Bowman complements his scientific achievements with business acumen. After improving on the above-mentioned membrane design, he identified major market applications such as printed circuit board manufacturing and mining. In conjunction, he initiated alliances with suppliers for designing and developing the film processing equipment.

Throughout his career, Bowman has proven an adept leader of the scientists, engineers and operating staff under his leadership. He has 10 patents in process development chemistry. Bowman received a Post Doctorate from UC Berkeley, a PhD from UC Santa Barbara, a MS from Princeton University and a BS from CSU at Long Beach, all in the field of Chemistry.

back to team